163 related articles for article (PubMed ID: 1973939)
1. A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting.
Böhm C; Placchi M; Stallone F; Gammans RE; Alms DR; Shrotriya RC; Robinson DS
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):38S-42S. PubMed ID: 1973939
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
Lemoine P; Rouillon F; Pouget D
Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
[TBL] [Abstract][Full Text] [Related]
3. Single daily dose treatment of anxiety with clobazam: a double-blind study versus normal multiple-dose treatment with diazepam.
Botter PA
Curr Med Res Opin; 1980; 6(9):593-7. PubMed ID: 6996930
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
[TBL] [Abstract][Full Text] [Related]
5. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
van Laar MW; Volkerts ER; van Willigenburg AP
J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
[TBL] [Abstract][Full Text] [Related]
7. Buspirone therapy in anxious elderly patients: a controlled clinical trial.
Böhm C; Robinson DS; Gammans RE; Shrotriya RC; Alms DR; Leroy A; Placchi M
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):47S-51S. PubMed ID: 2198301
[TBL] [Abstract][Full Text] [Related]
8. [Effect on vigilance of a single administration of clobazam].
Mikus P
Arzneimittelforschung; 1982; 32(11):1496-501. PubMed ID: 6129858
[TBL] [Abstract][Full Text] [Related]
9. Clobazam and diazepam in anxiety.
Rickels K; Brown AS; Cohen D; Harris H; Hurowitz A; Lindenbaum EJ; Ross HA; Weinstock R; Wiseman K; Zal M
Clin Pharmacol Ther; 1981 Jul; 30(1):95-100. PubMed ID: 6113074
[TBL] [Abstract][Full Text] [Related]
10. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
[TBL] [Abstract][Full Text] [Related]
11. Alprazolam compared to clobazam and placebo in anxious outpatients.
Castillo A; Sotillo C; Mariategui J
Neuropsychobiology; 1987; 18(4):189-94. PubMed ID: 2900483
[TBL] [Abstract][Full Text] [Related]
12. Mianserin is better tolerated and more effective in depression than a nomifensine-clobazam combination: a double-blind study.
Levin A; Schlebusch L
Acta Psychiatr Scand Suppl; 1985; 320():75-80. PubMed ID: 3863470
[TBL] [Abstract][Full Text] [Related]
13. Low doses of ketazolam in anxiety: a double-blind, placebo-controlled study.
Scarpini E; Baron PG; Bet L; Bottini G; Bresolin N; Meola G; Pezzoli G; Vallar G; Monza GC; Scarlato G
Neuropsychobiology; 1988; 20(2):74-7. PubMed ID: 2908133
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo.
Pecknold JC; Matas M; Howarth BG; Ross C; Swinson R; Vezeau C; Ungar W
Can J Psychiatry; 1989 Nov; 34(8):766-71. PubMed ID: 2684380
[TBL] [Abstract][Full Text] [Related]
15. Effects of single oral doses of bromazepam, buspirone and clobazam on performance tasks and memory.
Bourin M; Auget JL; Colombel MC; Larousse C
Neuropsychobiology; 1989; 22(3):141-5. PubMed ID: 2577220
[TBL] [Abstract][Full Text] [Related]
16. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
DeMartinis N; Rynn M; Rickels K; Mandos L
J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
Delle Chiaie R; Pancheri P; Casacchia M; Stratta P; Kotzalidis GD; Zibellini M
J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of buspirone and clobazam.
Alford C; Bhatti JZ; Curran S; McKay G; Hindmarch I
Br J Clin Pharmacol; 1991 Jul; 32(1):91-7. PubMed ID: 1679659
[TBL] [Abstract][Full Text] [Related]
19. Buspirone in the long-term treatment of generalized anxiety disorder.
Feighner JP
J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
[TBL] [Abstract][Full Text] [Related]
20. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
